Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02817061 · ClinicalTrials.gov registry record · Early Phase 1
Effectiveness of Light for Enhancement of Cognition by Transcranial Repeated Application (ELECTRA)
A Early Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
NCT02817061: Completed Early Phase 1 study, sponsored by Massachusetts General Hospital.
NCT02817061 is a Early Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02817061, a Early Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
Aim: Investigate whether transcranial photobiomodulation (tPBM) using near-infrared light exposure to the head, can improve frontal lobe executive function, working memory and overall mood in normal volunteer participants. Hypothesis: The investigators predict that tPBM will increase cognitive functioning, as measured by Cambridge Cognition cognitive testing in study subjects.
Interventions
- DEVICE Omnilux
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2019-09-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02817061
The ClinicalTrials.gov registry entry for NCT02817061 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omnilux is the first listed.
NCT02817061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02817061 about?
NCT02817061 is a clinical study titled "Effectiveness of Light for Enhancement of Cognition by Transcranial Repeated Application (ELECTRA)". Aim: Investigate whether transcranial photobiomodulation (tPBM) using near-infrared light exposure to the head, can improve frontal lobe executive function, working memory and overall mood in normal volunteer participants. Hypothesis: The investigators predict that tPBM will increase cognitive func...
What is the current status of trial NCT02817061?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2018-03-27. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT02817061?
The interventions under investigation include: Omnilux (DEVICE).
Who is sponsoring clinical trial NCT02817061?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.